Pembrolizumab (OAC): Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 18 March 2022 Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 1311KB) Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 320KB)